And for patients facing extreme limitations to mobility, or who live vast distances from hospitals and clinics, mobile ...
NICE has recommended natalizumab for adults with highly active RRMS, citing pregnancy suitability, biosimilar value and NHS ...
If approved, lecanemab may become the first and only anti-amyloid treatment in China to offer an at-home injection from the ...
GlobalData on MSN
Biogen’s Tysabri to be used on England’s NHS for highly active MS
NICE has recommended Tysabri and biosimilar Tyruko as an option for patients with highly active relapsing-remitting multiple ...
Here are all the latest Devil Hunter codes which provide Fiend Rerolls, Clan Rerolls, Eraser Devils, and more in the Roblox ...
Thousands of people in England with a type of multiple sclerosis (MS) are set to benefit from a new treatment on the NHS.
SaveHealth reports seven asthma medication categories, including inhaled corticosteroids and biologics, helping manage ...
StockStory.org on MSN
Q3 Earnings Outperformers: Novavax (NASDAQ:NVAX) And The Rest Of The Therapeutics Stocks
Looking back on therapeutics stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including Novavax ...
TipRanks on MSN
Biogen, Eisai say Leqembi BLA accepted in China
Eisai (ESALY) and Biogen (BIIB) announced that the Biologics License Application for the subcutaneous formulation of LEQEMBI, an anti-amyloid beta ...
6don MSN
These groundbreaking Alzheimer’s drugs slow brain decline by treating the actual cause of dementia
Two new groundbreaking drugs could slow the memory impairment, thinking skills and overall brain decline — and both are ...
Weihai Bank will raise about 1 billion yuan by selling new shares to an investment vehicle owned by municipal organizations ...
3don MSN
Saks owner races to raise $1B in financing as CEO steps down, possible bankruptcy looms: sources
There are ongoing discussions to potentially stave off a bankruptcy filing, a source with knowledge of the situation told The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results